900m lives depend on livestock

In 2018 GALVmed marks 10 years of activities focused on bringing effective livestock vaccines, medicines & diagnostics to millions of smallholder farmers in sub-Saharan Africa and South Asia

Read our GALVmed@10 report on achievements and lessons learned

Ten products have been delivered in the past decade.

Proof of concepts achieved for eight products.

A significant increase in scope and scale over a relatively short period.

The estimated value of livestock disease mortalities that has been averted is USD 167 million.

GALVmed@10

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Commercial development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.

Blog

Walking The Last Mile: Learn about our new project with Boehringer Ingelheim

In July 2018, GALVmed’s partner  Boehringer Ingelheim launched a new project known as The Last Mile Initiative. The project is designed to address weak distribution channels and help smallholder farmers in Africa increase their …

Bill Gates asks: Can goats empower women?

In a new article posted on his Gates Notes blog, Bill Gates says rearing goats can greatly boost women’s empowerment, especially in rural areas where money earned from sale of goats stays in the women’s …

Hester Biosciences launches innovative awareness campaign for smallholder farmers

GALVmed partner Hester Biosciences Limited has launched a campaign to sensitise farmers about animal health and management. The campaign is one of the initiatives to kick start a new programme which aims to provide over …